Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-25 @ 4:41 AM
NCT ID:
NCT02627118
Eligibility Criteria:
Inclusion Criteria:
* Male ESRD patients 18 years or older
* Stable on hemodialysis for more than 3 months
* Stable hematocrit equal to or above 29 %
* Stable vascular access
* Stable anticoagulation
* No active infection
* Able to sign informed consent and able to participate in the study
* Medically stable
Exclusion Criteria:
* Participation in another study which may interfere with the planned study
* Active infection
* Medical conditions which may interfere with the study (unstable cardiac status, chronic liver disease, active hepatitis as defined by elevated liver enzymes)
* Females (It is expected that potential changes in estrogenic activity that might be seen in patients exposed to BPA will be modest and would be masked by naturally occurring variability of estrogen activity in women at varying stages of gonadal activity (pre, post-menopausal, different points in menstrual cycle, eventual pregnancy, etc). Thus, limiting study to adult males will maximize the possibility of detecting any changes in estrogenic activity.)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02627118
Study Brief:
Protocol Section:
NCT02627118